The effect of Swastha Thriphala, an Ayurveda medicinal formulation on side-effects of therapy and quality of life in cancer patients

The effects of a herbal medicinal product, Swastha Thriphala, on the side effects of chemotherapy and radiotherapy in patients with cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2013/036

Enrollment

200

Registered

2013-11-29

Start date

2013-12-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Side effects of chemotherapy and radiotherapy in cancer

Interventions

Participants will be randomized into two arms. The intervention arm will receive Swastha Thriphala 750g to be taken orally twice daily for 30 days. The control arm will receive a standardized placeb

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consenting adults 20-70 years 2. With any diagnosed cancer 3. Receiving chemotherapy or radiotherapy (intervention will be given concomitantly with the chemotherapy/radiotherapy regimens) for cancer 4. Presenting to the Oncology Clinic Teaching Hospital Karapitiya, Galle.

Exclusion criteria

Exclusion criteria: Patients with diagnosed 1. Heart failure 2. Chronic kidney diseases 3. Respiratory diseases 4. Chronic liver diseases 5. Stroke 6. Dementia 7. Frailty 8. Parkinson disease

Design outcomes

Primary

Measure	Time frame
Haematological side effects (changes in neutrophil count, haemoglobin and platelets) [Baseline, 3 days, 7 days, 14 days and 30 days of treatment] Patient assessment of fatigue, sleep and hair loss [Baseline, 3 days, 7 days, 14 days and 30 days of treatment]	—

Secondary

Measure	Time frame
None [None]	—

Countries

Sri Lanka

Contacts

Public ContactProfessor Colvin Goonaratna

Registrar

si7np5e@gmail.com4 612 643

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026